中药发展战略
Search documents
太龙药业:公司当前生产经营正常
Zheng Quan Ri Bao· 2025-12-11 14:10
Core Viewpoint - The company emphasizes that its stock price is influenced by multiple market factors, including industry policies, market liquidity, and investor preferences, and encourages a rational approach to market fluctuations [2] Company Operations - The company confirms that its production and operations are currently normal and will continue to focus on its development strategy and operational goals [2] - The operational strategy includes strengthening its formulation, optimizing its herbal pieces, refining research and development, and expanding into traditional Chinese medicine [2] - The company aims to balance quality and efficiency while enhancing internal quality and strengthening management and core competitiveness to promote high-quality development and value enhancement [2]